Jaime Fernández-Sarmiento
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jaime Fernández-Sarmiento has a total of 791 co-authors. Here are the top co-authors by number of shared publications:
Lorena Acevedo
14 shared publicationsHernando Mulett
Department of Critical Care Medicine and Pediatrics, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia
11 shared publicationsCatalina Duque
Department of Critical Care Medicine and Pediatrics, Fundación Cardioinfantil-Instituto de Cardiología, Universidad de la Sabana, Bogotá, Colombia
5 shared publicationsJoseph A. Carcillo
UPMC Children's Hospital of Pittsburgh University of Pittsburgh
5 shared publicationsJuan David Bustos
Department of Pediatrics and Intensive Care, Universidad de La Sabana, Chía, Colombia
5 shared publicationsMauricio Sarta-Mantilla
Department of Critical Care Medicine and Pediatrics, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia
5 shared publications
Latest Publications
- 18 November 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Precannulation Risk Factors Associated With Hemorrhagic Events During Respiratory Extracorporeal Membrane Oxygenation in Children: A Multicenter Retrospective Study
Hemorrhagic complications are frequent and clinically significant during pediatric extracorporeal membrane oxygenation (ECMO), yet associated precannulation factors remain poorly defined. We evaluated these factors in a multicenter retrospective cohort of children receiving respiratory ECMO at four Colombian centers during 2018–2022. A total of 106 children were included; 53 (50.0%) developed at least one hemorrhagic complication during ECMO support, and 83% of events occurred within the first 7 days after cannulation. Cannulation-site bleeding was most frequent (41.5%), followed by intracranial hemorrhage (22.6%) and pulmonary hemorrhage (17.0%). In bias-reduced adjusted analyses, higher precannulation lactate concentrations, lower bicarbonate levels, previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, adenovirus infection at admission, and longer mechanical ventilation and vasoactive support before ECMO remained associated with bleeding. Patients who developed hemorrhagic complications had higher 28 day mortality than those without bleeding (39.6% vs . 13.2%; p = 0.002). When bleeding was modeled as a time-dependent exposure, hemorrhagic events were associated with a higher subsequent hazard of 28 day mortality (hazard ratio [HR], 4.93; 95% confidence interval [CI], 2.09–11.64). Hemorrhagic complications affected half of children receiving respiratory ECMO, occurred predominantly during the first week, and were associated with increased mortality. Several precannulation characteristics remained associated with bleeding in bias-reduced adjusted analyses. These hypothesis-generating findings require prospective validation.
- 18 November 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Precannulation Risk Factors Associated With Hemorrhagic Events During Respiratory Extracorporeal Membrane Oxygenation in Children: A Multicenter Retrospective Study
Hemorrhagic complications are frequent and clinically significant during pediatric extracorporeal membrane oxygenation (ECMO), yet associated precannulation factors remain poorly defined. We evaluated these factors in a multicenter retrospective cohort of children receiving respiratory ECMO at four Colombian centers during 2018–2022. A total of 106 children were included; 53 (50.0%) developed at least one hemorrhagic complication during ECMO support, and 83% of events occurred within the first 7 days after cannulation. Cannulation-site bleeding was most frequent (41.5%), followed by intracranial hemorrhage (22.6%) and pulmonary hemorrhage (17.0%). In bias-reduced adjusted analyses, higher precannulation lactate concentrations, lower bicarbonate levels, previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, adenovirus infection at admission, and longer mechanical ventilation and vasoactive support before ECMO remained associated with bleeding. Patients who developed hemorrhagic complications had higher 28 day mortality than those without bleeding (39.6% vs . 13.2%; p = 0.002). When bleeding was modeled as a time-dependent exposure, hemorrhagic events were associated with a higher subsequent hazard of 28 day mortality (hazard ratio [HR], 4.93; 95% confidence interval [CI], 2.09–11.64). Hemorrhagic complications affected half of children receiving respiratory ECMO, occurred predominantly during the first week, and were associated with increased mortality. Several precannulation characteristics remained associated with bleeding in bias-reduced adjusted analyses. These hypothesis-generating findings require prospective validation.
- 13 November 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Sepsis Point Prevalence Across Ibero-Latin America PICUs: The 2024 Sepsis Prevalence Assessment Database in Pediatrics (SPREAD PED IBERO-LATAM)
Objectives: To determine the prevalence and outcome of sepsis in PICUs across Ibero-Latin America; to identify patient- and institution-level factors associated with mortality; and to explore the prognostic performance of pediatric sepsis definitions. Design: Multinational, multicenter, prospective point prevalence study with follow-up to hospital discharge. Setting: One hundred sixty-eight PICUs in 21 countries across Latin America, Spain, and Portugal. Patients: Children of 28 days to 18 years with a clinical diagnosis of sepsis or septic shock admitted to participating PICUs between September 9 and September 13, 2024. Interventions: None Measurements and Main Results: Among 1318 screened PICU patients, 340 met criteria for clinical sepsis, yielding a point prevalence of 25.8% (95% CI, 23.5–28.2%). Complete outcome data were available for 324 patients. PICU mortality was 42 of 324 (13.0% [95% CI, 9.5–17.1%), and total in-hospital mortality was 49 of 324 (15.1% [95% CI, 11.4–19.4%]). Cardiovascular and respiratory dysfunction were most frequent, whereas multivariable logistic regression identified greater odds of PICU mortality associated with renal dysfunction (adjusted odds ratio [aOR], 3.2 [95% CI, 1.5–7.5]) and immunologic dysfunction (aOR, 12.7 [95% CI, 4.6–37.5]).In multivariable analysis, abnormal nutritional status, lack of vaccination, renal dysfunction, and admission to PICUs with intermediate or low resource availability were associated with greater odds of PICU mortality. In exploratory analyses, the Phoenix sepsis criteria identified 95.2% of PICU deaths, but the positive predictive value of the score for mortality was no different from the 2005 International Pediatric Sepsis Consensus Conference criteria. Conclusions: In 2024, in Ibero-Latin American PICUs, sepsis affected approximately one in four admissions, and the diagnosis was associated with mortality. Both patient vulnerability and institutional resource availability were associated with greater odds of mortality, underscoring the potential influence of health system capacity on pediatric sepsis outcomes in the region.
- 13 November 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Sepsis Point Prevalence Across Ibero-Latin America PICUs: The 2024 Sepsis Prevalence Assessment Database in Pediatrics (SPREAD PED IBERO-LATAM)
Objectives: To determine the prevalence and outcome of sepsis in PICUs across Ibero-Latin America; to identify patient- and institution-level factors associated with mortality; and to explore the prognostic performance of pediatric sepsis definitions. Design: Multinational, multicenter, prospective point prevalence study with follow-up to hospital discharge. Setting: One hundred sixty-eight PICUs in 21 countries across Latin America, Spain, and Portugal. Patients: Children of 28 days to 18 years with a clinical diagnosis of sepsis or septic shock admitted to participating PICUs between September 9 and September 13, 2024. Interventions: None Measurements and Main Results: Among 1318 screened PICU patients, 340 met criteria for clinical sepsis, yielding a point prevalence of 25.8% (95% CI, 23.5–28.2%). Complete outcome data were available for 324 patients. PICU mortality was 42 of 324 (13.0% [95% CI, 9.5–17.1%), and total in-hospital mortality was 49 of 324 (15.1% [95% CI, 11.4–19.4%]). Cardiovascular and respiratory dysfunction were most frequent, whereas multivariable logistic regression identified greater odds of PICU mortality associated with renal dysfunction (adjusted odds ratio [aOR], 3.2 [95% CI, 1.5–7.5]) and immunologic dysfunction (aOR, 12.7 [95% CI, 4.6–37.5]).In multivariable analysis, abnormal nutritional status, lack of vaccination, renal dysfunction, and admission to PICUs with intermediate or low resource availability were associated with greater odds of PICU mortality. In exploratory analyses, the Phoenix sepsis criteria identified 95.2% of PICU deaths, but the positive predictive value of the score for mortality was no different from the 2005 International Pediatric Sepsis Consensus Conference criteria. Conclusions: In 2024, in Ibero-Latin American PICUs, sepsis affected approximately one in four admissions, and the diagnosis was associated with mortality. Both patient vulnerability and institutional resource availability were associated with greater odds of mortality, underscoring the potential influence of health system capacity on pediatric sepsis outcomes in the region.
- 12 November 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Electrical Cardiometry for Non-Invasive Cardiac Output Monitoring in Neonatal and Pediatric Critical Care: A Bayesian Systematic Review and Meta-Analysis
Objectives: To evaluate the agreement between electrical cardiometry and established reference methods for cardiac output measurement in neonatal and pediatric critical care using Bayesian meta-analysis, while synthesizing evidence on stroke volume bias, prognostic associations, and hemodynamic-guided management. Design: Systematic review and Bayesian hierarchical random-effects meta-analysis conducted according to PRISMA 2020 recommendations. Setting: Neonatal and pediatric intensive care units, emergency care settings, and interhospital transport services. Data Sources: MEDLINE via PubMed, Embase, Google Scholar, and ScienceDirect were searched from database inception through March 2026. Reference lists and forward citation tracking were additionally performed to identify eligible studies. Measurements and Main Results: Six studies including 448 neonates and children met the eligibility criteria. Three method-comparison studies enrolled 223 participants, of which two studies comprising 193 participants and four datasets contributed to the primary Bayesian synthesis. The pooled posterior mean percentage error was 26.9% (95% credible interval [CrI], 24.3%–29.5%), with a 98.3% posterior probability that the true percentage error remained ≤30%. A secondary analysis showed a pooled stroke volume bias of 2.82 mL (95% CrI, 1.71-3.86) and a 99.5% posterior probability that the absolute bias remained <5 mL. Observational evidence associated lower cardiac output with longer mechanical ventilation, while a pilot randomized trial suggested that electrical cardiometry-guided management reduced fluid administration and accelerated vasoactive therapy initiation. Conclusions: Pooled evidence indicated a high posterior probability of clinically acceptable agreement between electrical cardiometry and reference methods for cardiac output measurement. Its prognostic and therapeutic value should be confirmed in larger multicenter prospective studies.
- 12 November 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Electrical Cardiometry for Non-Invasive Cardiac Output Monitoring in Neonatal and Pediatric Critical Care: A Bayesian Systematic Review and Meta-Analysis
Objectives: To evaluate the agreement between electrical cardiometry and established reference methods for cardiac output measurement in neonatal and pediatric critical care using Bayesian meta-analysis, while synthesizing evidence on stroke volume bias, prognostic associations, and hemodynamic-guided management. Design: Systematic review and Bayesian hierarchical random-effects meta-analysis conducted according to PRISMA 2020 recommendations. Setting: Neonatal and pediatric intensive care units, emergency care settings, and interhospital transport services. Data Sources: MEDLINE via PubMed, Embase, Google Scholar, and ScienceDirect were searched from database inception through March 2026. Reference lists and forward citation tracking were additionally performed to identify eligible studies. Measurements and Main Results: Six studies including 448 neonates and children met the eligibility criteria. Three method-comparison studies enrolled 223 participants, of which two studies comprising 193 participants and four datasets contributed to the primary Bayesian synthesis. The pooled posterior mean percentage error was 26.9% (95% credible interval [CrI], 24.3%–29.5%), with a 98.3% posterior probability that the true percentage error remained ≤30%. A secondary analysis showed a pooled stroke volume bias of 2.82 mL (95% CrI, 1.71-3.86) and a 99.5% posterior probability that the absolute bias remained <5 mL. Observational evidence associated lower cardiac output with longer mechanical ventilation, while a pilot randomized trial suggested that electrical cardiometry-guided management reduced fluid administration and accelerated vasoactive therapy initiation. Conclusions: Pooled evidence indicated a high posterior probability of clinically acceptable agreement between electrical cardiometry and reference methods for cardiac output measurement. Its prognostic and therapeutic value should be confirmed in larger multicenter prospective studies.
- Open Access
- 7 November 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 65
Pediatric intensive care resources in Ibero-Latin America: SPREAD PED Ibero–Latin America, a multinational, multicentre, cross-sectional study
- 7 November 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 65
Open AccessPediatric intensive care resources in Ibero-Latin America: SPREAD PED Ibero–Latin America, a multinational, multicentre, cross-sectional study
- Open Access
- 9 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2839
Clinical Utility of a Feedback Device in High-Quality Cardiopulmonary Resuscitation: The Guardian Angel
Background/Objectives: High-quality cardiopulmonary resuscitation (CPR) is essential for improving clinical outcomes in patients experiencing cardiac arrest. Feedback devices designed to guide CPR must offer real-time feedback on chest compression quality for use by both medical personnel and laypersons. To describe the impact of using an infrared-based device to provide feedback on chest compression quality during CPR performed by healthcare personnel. Methods: A before-and-after study conducted in a simulated hospital from February 2019 to February 2020 evaluated the difference in the percentage of adequate chest compressions in depth and rate. This was assessed by comparing the number of adequate compressions to the total performed in one minute, both with and without the use of a feedback device. Results: A total of 90 participants were recruited, with an average age of 31.2 years (SD: 8.86), of which 60% (54/90) were women. In infants and schoolchildren/adults, high-quality compressions improved by 66% (85% vs. 19%; p < 0.001) and 54% (79% vs. 25%; p < 0.001), respectively, when guided by the GA compared to the control group. In participants without training and experience in CPR, the use of the Guardian Angel achieved high-quality compressions of 45% (10/22) and 66% (25/42), respectively, when evaluating depth for the schoolchildren/adults group. The use of the device during CPR, even in situations of moderate or severe fatigue, resulted in an improvement in high-quality compressions in terms of frequency, reaching 73% (16/22) in infants and 68% (15/22) in schoolchildren/adults. Conclusions: The Guardian Angel improves both the frequency and depth of compressions in participants without previous CPR experience or training. Additionally, the device demonstrated notable improvements in compression frequency, even in situations of moderate or severe fatigue.
- 9 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2839
Open AccessClinical Utility of a Feedback Device in High-Quality Cardiopulmonary Resuscitation: The Guardian Angel
Background/Objectives: High-quality cardiopulmonary resuscitation (CPR) is essential for improving clinical outcomes in patients experiencing cardiac arrest. Feedback devices designed to guide CPR must offer real-time feedback on chest compression quality for use by both medical personnel and laypersons. To describe the impact of using an infrared-based device to provide feedback on chest compression quality during CPR performed by healthcare personnel. Methods: A before-and-after study conducted in a simulated hospital from February 2019 to February 2020 evaluated the difference in the percentage of adequate chest compressions in depth and rate. This was assessed by comparing the number of adequate compressions to the total performed in one minute, both with and without the use of a feedback device. Results: A total of 90 participants were recruited, with an average age of 31.2 years (SD: 8.86), of which 60% (54/90) were women. In infants and schoolchildren/adults, high-quality compressions improved by 66% (85% vs. 19%; p < 0.001) and 54% (79% vs. 25%; p < 0.001), respectively, when guided by the GA compared to the control group. In participants without training and experience in CPR, the use of the Guardian Angel achieved high-quality compressions of 45% (10/22) and 66% (25/42), respectively, when evaluating depth for the schoolchildren/adults group. The use of the device during CPR, even in situations of moderate or severe fatigue, resulted in an improvement in high-quality compressions in terms of frequency, reaching 73% (16/22) in infants and 68% (15/22) in schoolchildren/adults. Conclusions: The Guardian Angel improves both the frequency and depth of compressions in participants without previous CPR experience or training. Additionally, the device demonstrated notable improvements in compression frequency, even in situations of moderate or severe fatigue.
- Open Access
- 5 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 61
Microvascular phenotypes in pediatric sepsis identified by machine learning: prognostic implications for organ dysfunction and mortality
Pediatric sepsis exhibits marked heterogeneity. Early integration of clinical, biomarker, and microcirculatory data may refine risk stratification and iden
- 5 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 61
Open AccessMicrovascular phenotypes in pediatric sepsis identified by machine learning: prognostic implications for organ dysfunction and mortality
Pediatric sepsis exhibits marked heterogeneity. Early integration of clinical, biomarker, and microcirculatory data may refine risk stratification and iden
- Open Access
- 9 January 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1725990
AEIOU strategy for continuous renal replacement therapy in infants <10 kg: a practical and educational framework
Continuous renal replacement therapy (CRRT) has become a cornerstone in the management of critically ill children with severe acute kidney injury (AKI) and fluid overload. However, its use in neonates and infants weighing less than 10 kg remains particularly challenging due to limited circulating volumes, higher risks of hemodynamic instability, and the scarcity of devices specifically designed for this population. In recent years, new platforms have been introduced, enabling safer extracorporeal support for the smallest patients. Although early experiences suggest that these technologies are feasible and safe, survival outcomes in this fragile group remain suboptimal, and standardized guidelines are still lacking. To address this gap, we propose the AEIOU strategy, an educational and practical framework aimed at organizing and simplifying the essential components required for safe and effective CRRT in infants under 10 kg. AEIOU summarizes: A ( Alerts: indications, risks, and contraindications ), E ( Execution Team) , I ( Inputs: catheters, machines, filters, and solutions ), O ( Orders: prescription components such as priming, anticoagulation, blood and effluent flow rates ), and U ( Unified record: standardized documentation of therapy variables and outcomes) . By integrating existing literature with a reproducible mnemonic, AEIOU provides a structured tool for training clinical teams, ensuring quality of care, and laying the foundation for collaborative research. Beyond CRRT, this framework may be adaptable to other extracorporeal therapies in pediatrics. The AEIOU strategy offers a simple yet comprehensive guide to improve implementation, education, and outcome monitoring of CRRT in neonates and small infants.
- 9 January 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1725990
Open AccessAEIOU strategy for continuous renal replacement therapy in infants <10 kg: a practical and educational framework
Continuous renal replacement therapy (CRRT) has become a cornerstone in the management of critically ill children with severe acute kidney injury (AKI) and fluid overload. However, its use in neonates and infants weighing less than 10 kg remains particularly challenging due to limited circulating volumes, higher risks of hemodynamic instability, and the scarcity of devices specifically designed for this population. In recent years, new platforms have been introduced, enabling safer extracorporeal support for the smallest patients. Although early experiences suggest that these technologies are feasible and safe, survival outcomes in this fragile group remain suboptimal, and standardized guidelines are still lacking. To address this gap, we propose the AEIOU strategy, an educational and practical framework aimed at organizing and simplifying the essential components required for safe and effective CRRT in infants under 10 kg. AEIOU summarizes: A ( Alerts: indications, risks, and contraindications ), E ( Execution Team) , I ( Inputs: catheters, machines, filters, and solutions ), O ( Orders: prescription components such as priming, anticoagulation, blood and effluent flow rates ), and U ( Unified record: standardized documentation of therapy variables and outcomes) . By integrating existing literature with a reproducible mnemonic, AEIOU provides a structured tool for training clinical teams, ensuring quality of care, and laying the foundation for collaborative research. Beyond CRRT, this framework may be adaptable to other extracorporeal therapies in pediatrics. The AEIOU strategy offers a simple yet comprehensive guide to improve implementation, education, and outcome monitoring of CRRT in neonates and small infants.
- Open Access
- 7 January 2026
- Published by Ediciones Prado in Critical Care & Emergency Medicine
- Vol. 5, 118-133
Terapia de fluidos guiada por ecografía en el paciente crítico pediátrico: integrando tolerancia y respuesta a fluidos
Optimal intravenous fluid administration in critically ill patients is essential for effective hemodynamic management, particularly during episodes of shock. Over time, fluid resuscitation strategies have evolved from liberal approaches to restrictive and individualized methods in order to prevent both hypovolemia and fluid overload, especially considering that only about 50% of critically ill patients are truly fluid responsive. Point-of-care ultrasound (POCUS) has emerged as a valuable, noninvasive bedside tool for assessing intravascular volume status and real-time hemodynamics. Several ultrasound-based techniques can be used, including cardiac ultrasound to evaluate preload, contractility, and afterload; lung ultrasound to detect pulmonary edema; and the Venous Excess Ultrasound Score (VExUS) to assess visceral venous congestion. These ultrasound assessments provide essential information on fluid responsiveness, right ventricular function, and tolerance to additional fluid administration. This enables clinicians to optimize fluid therapy while minimizing complications related to fluid overload. The integration of POCUS into clinical practice improves the ability of pediatric intensivists to tailor treatments to each patient’s hemodynamic profile, ultimately enhancing clinical outcomes. The combination of ultrasound and hemodynamic evaluation opens new possibilities for precision fluid management in the resuscitation of critically ill pediatric patients.
- 7 January 2026
- Published by Ediciones Prado in Critical Care & Emergency Medicine
- Vol. 5, 118-133
Open AccessTerapia de fluidos guiada por ecografía en el paciente crítico pediátrico: integrando tolerancia y respuesta a fluidos
Optimal intravenous fluid administration in critically ill patients is essential for effective hemodynamic management, particularly during episodes of shock. Over time, fluid resuscitation strategies have evolved from liberal approaches to restrictive and individualized methods in order to prevent both hypovolemia and fluid overload, especially considering that only about 50% of critically ill patients are truly fluid responsive. Point-of-care ultrasound (POCUS) has emerged as a valuable, noninvasive bedside tool for assessing intravascular volume status and real-time hemodynamics. Several ultrasound-based techniques can be used, including cardiac ultrasound to evaluate preload, contractility, and afterload; lung ultrasound to detect pulmonary edema; and the Venous Excess Ultrasound Score (VExUS) to assess visceral venous congestion. These ultrasound assessments provide essential information on fluid responsiveness, right ventricular function, and tolerance to additional fluid administration. This enables clinicians to optimize fluid therapy while minimizing complications related to fluid overload. The integration of POCUS into clinical practice improves the ability of pediatric intensivists to tailor treatments to each patient’s hemodynamic profile, ultimately enhancing clinical outcomes. The combination of ultrasound and hemodynamic evaluation opens new possibilities for precision fluid management in the resuscitation of critically ill pediatric patients.
- Open Access
- 1 January 2026
- Published by GRAPHIMEDIC SA DE CV in Revista Mexicana de Pediatría
- Vol. 93 (2) , 87-93
Sepsis pediátrica en la era de la Surviving Sepsis Campaign 2026: de la reanimación, a la medicina de precisión y el seguimiento a largo plazo
- 1 January 2026
- Published by GRAPHIMEDIC SA DE CV in Revista Mexicana de Pediatría
- Vol. 93 (2) , 87-93
Open AccessSepsis pediátrica en la era de la Surviving Sepsis Campaign 2026: de la reanimación, a la medicina de precisión y el seguimiento a largo plazo
- Open Access
- 21 November 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1719260
Adverse events and predictive probability of peripheral vasopressor administration in pediatric shock: integrating frequentist and hierarchical Bayesian meta-analyses
Background: Pediatric shock demands early vasoactive therapy to restore perfusion. When central access is delayed—particularly in resource-limited settings—peripheral vasopressors provide a feasible alternative. This systematic review and hierarchical Bayesian meta-analysis synthesized current evidence on peripheral vasopressor use in children, estimating incidence, characteristics, and probabilistic risk of local complications to inform safe clinical practice. Methods: We systematically searched PubMed/MEDLINE, EMBASE, LILACS, Google Scholar, and the Cochrane Library (January 1990–March 2025) using MeSH and free-text terms for vasoactive agents, peripheral intravenous access, pediatric populations, and adverse events. Studies including children aged 1 month–18 years who received peripheral vasopressors and reported local complications were eligible. Two reviewers independently extracted data and assessed study quality using the Joanna Briggs Institute (JBI) checklist. The primary outcome was the pooled proportion of local adverse events. Frequentist and hierarchical Bayesian logistic models estimated pooled rates, 95% confidence or credible intervals, and predictive uncertainty. Weakly informative priors {half-Cauchy for random effects, normal [(0,1)] for log-odds} were applied, and posterior estimates derived via Markov Chain Monte Carlo (four chains, 2,000 iterations, R^ < 1.01). Results: Eleven studies comprising 1,575 pediatric patients were included. The pooled incidence of local adverse events was 1.97% (95% CI, 1.41–2.82) with no severe complications such as necrosis, ischemia, or need for surgery. The Bayesian model yielded a consistent pooled rate of 1.8% (CrI95%, 1.0–2.8), with a 68% probability of being below 2% and 99% below 3%. Predictive intervals suggested new studies of 100–300 patients would show rates between 0% and 5%, confirming reproducibility. Subgroup analyses revealed no meaningful differences by setting or catecholamine type. Most events were mild extravasations after a median infusion of 4.1 h (IQR, 2.9–7.1). Conclusions: Peripheral vasopressor administration in pediatric shock is associated with a very low incidence of local adverse events. The Bayesian hierarchical model confirmed these findings with high probabilistic confidence, supporting peripheral administration as a safe and rapid approach for early hemodynamic stabilization. Peripheral vasopressors may be used for short durations (typically <4 h, according to the included studies) while central access is being established, thereby minimizing delays in critical resuscitation. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251115788 , identifier CRD420251115788.
- 21 November 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1719260
Open AccessAdverse events and predictive probability of peripheral vasopressor administration in pediatric shock: integrating frequentist and hierarchical Bayesian meta-analyses
Background: Pediatric shock demands early vasoactive therapy to restore perfusion. When central access is delayed—particularly in resource-limited settings—peripheral vasopressors provide a feasible alternative. This systematic review and hierarchical Bayesian meta-analysis synthesized current evidence on peripheral vasopressor use in children, estimating incidence, characteristics, and probabilistic risk of local complications to inform safe clinical practice. Methods: We systematically searched PubMed/MEDLINE, EMBASE, LILACS, Google Scholar, and the Cochrane Library (January 1990–March 2025) using MeSH and free-text terms for vasoactive agents, peripheral intravenous access, pediatric populations, and adverse events. Studies including children aged 1 month–18 years who received peripheral vasopressors and reported local complications were eligible. Two reviewers independently extracted data and assessed study quality using the Joanna Briggs Institute (JBI) checklist. The primary outcome was the pooled proportion of local adverse events. Frequentist and hierarchical Bayesian logistic models estimated pooled rates, 95% confidence or credible intervals, and predictive uncertainty. Weakly informative priors {half-Cauchy for random effects, normal [(0,1)] for log-odds} were applied, and posterior estimates derived via Markov Chain Monte Carlo (four chains, 2,000 iterations, R^ < 1.01). Results: Eleven studies comprising 1,575 pediatric patients were included. The pooled incidence of local adverse events was 1.97% (95% CI, 1.41–2.82) with no severe complications such as necrosis, ischemia, or need for surgery. The Bayesian model yielded a consistent pooled rate of 1.8% (CrI95%, 1.0–2.8), with a 68% probability of being below 2% and 99% below 3%. Predictive intervals suggested new studies of 100–300 patients would show rates between 0% and 5%, confirming reproducibility. Subgroup analyses revealed no meaningful differences by setting or catecholamine type. Most events were mild extravasations after a median infusion of 4.1 h (IQR, 2.9–7.1). Conclusions: Peripheral vasopressor administration in pediatric shock is associated with a very low incidence of local adverse events. The Bayesian hierarchical model confirmed these findings with high probabilistic confidence, supporting peripheral administration as a safe and rapid approach for early hemodynamic stabilization. Peripheral vasopressors may be used for short durations (typically <4 h, according to the included studies) while central access is being established, thereby minimizing delays in critical resuscitation. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251115788 , identifier CRD420251115788.